科伦博泰生物 港股通 空最新增减持 (2026-06-30) 官网 ( 06990.hk) | -289.08 | 22.69 | 0% | 上市时间2023-07-11股价514.00港币涨跌幅-1.44%成交金额4.12亿港币换手率0.33%市值1,228.58亿港币H股市值908.87亿港币总股本2.39亿H股本1.77亿每手股数100上市至今年化投资收益率100.70%港股通持仓占H股比例26.14% (238.96亿港币2026-07-22) 累计做空占H股比例3.52% (30.31亿港币2026-07-17) | |||
| 所属三级行业生物技术 (恒生) | 市盈率 | 122.29 | 市净率 | 4.46 | 股息率 | 0.37% | 恒生:医疗保健业药品及生物科技生物技术 |
| 所属指数指数纳入纳出 |
| ||||||
| 备注 (3): | 双击编辑备注 |
科伦博泰生物(06990) - 历史董事名单
| # | 姓名 | 职衔 | 职位 | 委任日期 | 辞任日期 |
|---|---|---|---|---|---|
| 1 | 金錦萍 | Independent Non Executive Director | 2023-07-11 | -- | |
| 2 | 李越冬 | Independent Non Executive Director | 2023-07-11 | -- | |
| 3 | 涂文偉 | Independent Non Executive Director | 2023-07-11 | -- | |
| 4 | 鄭強 | Independent Non Executive Director | 2023-07-11 | -- | |
| 5 | 曾學波 | Non Executive Director | 2022-07-30 | -- | |
| 6 | 葛均友 | Executive Director | 2022-02-25 | -- | |
| 7 | 李東方 | Non Executive Director | 2022-02-25 | -- | |
| 8 | 馮昊 | Non Executive Director | 2021-02-12 | -- | |
| 9 | 劉革新 | Non Executive Director | Chairman | 2016-11-22 | -- |
| 10 | 劉思川 | Non Executive Director | 2016-11-22 | -- | |
| 11 | 王晶翼 | Executive Director | 2016-11-22 | -- |